Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
SB-3CT: A Causal Probe of MMP9–PNN Biology
2026-09-28
The Adamtsl3–MMP9–perineuronal-net axis offers a compelling model for studying extracellular-matrix control of cortical plasticity. This thought-leadership article explains how SB-3CT can help translational researchers move from correlation to causal testing while preserving the distinction between MMP-9 biology, MMP-2 activity, preclinical evidence, and clinical relevance.
-
Prevotella copri Depletes IPA to Promote Breast Cancer
2026-09-28
A 2024 study links gut enrichment of Prevotella copri with lower host indole-3-pyruvic acid (IPA) and faster breast tumor growth in mouse models. Its proposed mechanism connects microbial tryptophan consumption to UHRF1-associated suppression of AMPK signaling, identifying a testable microbiome–metabolite pathway rather than establishing a clinical cause of breast cancer progression.
-
Carboplatin Resistance: Better TNBC Assay Design
2026-09-27
Carboplatin response in triple-negative breast cancer depends on more than drug exposure: stem-like cell state and DNA repair can shape apparent resistance. This guide turns the IGF2BP3–FZD1/7 findings into practical assay-design decisions for preclinical oncology research.
-
Cy3 Goat Anti-Mouse IgG (H+L) Antibody Guide
2026-09-26
Cy3 Goat Anti-Mouse IgG (H+L) Antibody is a fluorescent mouse IgG detection antibody for visualizing mouse primary antibodies in immunofluorescence, flow cytometry, and western blotting. Use it only after confirming primary-antibody compatibility and assay controls; it is for research use only, not diagnostic or medical use, and its preservative makes it unsuitable to assume compatibility with live-cell functional assays.
-
ML385: NRF2 Inhibition for Ferroptosis Research
2026-09-25
ML385 provides a pharmacological way to test whether NRF2 activity contributes to stress adaptation, ferroptosis-related readouts, or treatment resistance. This guide connects its established use in lung cancer models with a reference study of NRF2-dependent alcoholic liver injury, while distinguishing published conditions from practical pilot recommendations.
-
ALC-0159 PEG Lipid and mRNA Antigen Imaging
2026-09-25
ALC-0159 is a PEG-conjugated lipid excipient for mRNA lipid nanoparticle formulations, not an antigen-imaging reporter. The ALC-0159 PEG lipid can be discussed alongside PET methods for measuring tagged antigen expression, but the cited imaging study does not establish that it used ALC-0159.
-
Persistent rDNA Damage Triggers PML-Nucleolar Compartments
2026-09-24
Urbancokova, Hornofova and colleagues show that persistent lesions in ribosomal DNA, particularly following topological stress and RNA polymerase I inhibition, can trigger PML-nucleolar associations. Their combination of chemical perturbations, targeted rDNA cleavage and repair-pathway interventions links these structures to damaged, resected DNA and cellular senescence, while leaving open whether PML associations actively improve repair or mainly mark unresolved lesions.
-
Tofacitinib Citrate in Endothelial Inflammation Research
2026-09-24
Tofacitinib citrate (CP-690550 citrate) can help researchers probe immune signaling, but endothelial inflammation models reveal why cytokine, concentration, and endpoint choices matter. This article interprets comparative JAK-inhibitor findings and turns them into careful assay-design decisions.
-
TRPV1 Antagonism as a Probe of Stress Signaling
2026-09-23
AMG 9810 offers a selective way to interrogate TRPV1-dependent calcium and sensory-neuropeptide responses. Considered alongside new AMPK–SQSTM1/p62 findings, it can help translational researchers distinguish receptor-proximal sensory signaling from broader metabolic-stress adaptation—without assuming the pathways are already proven to intersect.
-
Nanoparticle Uptake by Human Corneal Epithelial Cells
2026-09-23
This 2024 study clarifies how nanoparticle size and surface chemistry shape uptake by human corneal epithelial cells in a mucosal model. Its main practical contribution is linking polymeric nanoparticle design with energy-dependent endocytosis, while identifying macropinocytosis and caveolae-mediated uptake as dominant pathways under the tested conditions.
-
Ruthenium Red in Mechanobiology Translation
2026-09-22
A mechanistic and strategic guide to using Ruthenium Red as a Ca2+ transport inhibitor in calcium signaling research, with particular emphasis on cytoskeleton-dependent mechanical stress, autophagy, assay design, and translational interpretation.
-
BI 2536: Interpreting PLK1-Driven Drug Responses
2026-09-22
BI 2536 is a selective PLK1 inhibitor for studying mitotic arrest, apoptosis, and tumor biology. This guide combines its pharmacology with a response-measurement framework that separates growth inhibition from true cell killing for more rigorous cancer research.
-
Proteinase K: Translational Control of Proteolysis
2026-09-21
Proteinase K is more than a routine digestion reagent. Its broad substrate tolerance, inhibitor resistance, and compatibility with demanding buffer conditions make it a strategic tool for high-integrity DNA workflows and for designing better protease selectivity controls. This article connects molecular mechanism, assay validation, and translational decision-making without confusing broad protein hydrolysis with target-specific inhibition.
-
Nonivamide: TRPV1 Workflows for Cancer Research
2026-09-21
Nonivamide combines selective TRPV1 activation with reported cancer cell growth inhibition, making it useful for parallel oncology and neuroimmune assays. This guide translates the evidence into practical stock preparation, cell-based apoptosis workflows, inflammation-focused experiments, and troubleshooting decisions.
-
UBR1 and UBR2 in ER Stress Protein Quality Control
2026-09-20
The reference study identifies the N-recognin E3 ligases UBR1 and UBR2 as stress-responsive regulators of mammalian protein quality control. Its findings connect their stress-dependent stabilization and proteasome-linked turnover with protection against endoplasmic reticulum stress-induced apoptosis, highlighting a previously underappreciated role for the N-degron pathway in ER-associated degradation.